IRIS BOSSE: Open Payments
NPI 1073130688 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 23 payments from 8 companies in 2025. Trend: 2023 $755 · 2024 $673 · 2025 $769
Food & beverage: $670Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $300 |
| Janssen Biotech, Inc. | 4 | $215 |
| Regeneron Healthcare Solutions, Inc. | 2 | $142 |
| Ardelyx, Inc. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, IBSRELA, LINZESS, VOQUEZNA, IQIRVO.
Industry payments across FL — which companies pay providers there.
